Yale University

The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.

TitleThe SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
Publication TypeJournal Article
Year of Publication2010
AuthorsAbdool Karim, Quarraisha, Salim S. Abdool Karim, Cheryl Baxter, Gerald Friedland, Tanuja Gengiah, Andrew Gray, Anneke Grobler, Kogileum Naidoo, Nesri Padayatchi, and Wafaa El-Sadr
JournalSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Volume100
Issue12
Pagination808-9
Date Published2010 Dec
ISSN0256-9574
KeywordsAnti-Retroviral Agents, Antitubercular Agents, Clinical Trials as Topic, Drug Therapy, Combination, HIV, HIV Infections, Humans, South Africa, Tuberculosis
DOI10.3109/00952990.2011.568081
Alternate JournalS. Afr. Med. J.

External Links